arrow_back Entities

DYSRUPTX LTD

active Private Limited Company
🇬🇧 GB | Incorporated 2022-05-06 | Reg. SC731650 | Data as of 2026-06-01
72110 - Research and experimental development on biotechnology

DYSRUPTX LTD is a private limited company registered in the United Kingdom, under SC731650, incorporated on 6 May 2022. The company is currently active. Operates in the research and experimental development on biotechnology sector (SIC 72110). The company has been operating for 4 years. Registered office address: G12 8QQ Glasgow, the United Kingdom. Formerly known as DISRUPTYX THERAPEUTICS LIMITED. Directors include DR. CONNOR MACLEOD BLAIR and DR DECLAN PATRICK DOOGAN. Shareholders include PROFESSOR GEORGE SCOTT BAILLIE and DR. CONNOR MACLEOD BLAIR. Associated with 1 related entity, including SC449608. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.

bookmark_add Save this entity to a watchlist · Get alerts on changes · API access
Sign up free

Official Identifiers

REGISTRATION NUMBER SC731650

Name Registry

FORMER

DISRUPTYX THERAPEUTICS LIMITED

FORMER

DISRUPTYVE THERAPEUTICS LIMITED

Registered Address

11 THE SQUARE
UNIVERSITY AVENUE
G12 8QQ GLASGOW
the United Kingdom

Signal Intelligence

verified

No sanctions, PEP status, or adverse risk signals are currently on record for this entity.

Key Management & Controllers

person DR. CONNOR MACLEOD BLAIR
50-75% DIRECTOR SHAREHOLDER
person DR DECLAN PATRICK DOOGAN
DIRECTOR
person PROFESSOR GEORGE SCOTT BAILLIE
25-50% SHAREHOLDER

Associated Entities

Companies sharing one or more directors or officers with this entity.

🇬🇧 SC449608

Source Records (1)

companieshouse SC731650 2026-06-01 open_in_new
Save entities, get alerts on changes, API access Sign up free